AQ-13   Click here for help

GtoPdb Ligand ID: 10391

Synonyms: Ro 47-0543
Antimalarial Ligand
Compound class: Synthetic organic
Comment: AQ-13 is a 4-aminoquinoline antimalarial compound related to chloroquine [3,7].

The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 28.16
Molecular weight 291.15
XLogP 3.45
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES CCN(CCCNc1ccnc2c1ccc(c2)Cl)CC
Isomeric SMILES CCN(CCCNc1ccnc2c1ccc(c2)Cl)CC
InChI InChI=1S/C16H22ClN3/c1-3-20(4-2)11-5-9-18-15-8-10-19-16-12-13(17)6-7-14(15)16/h6-8,10,12H,3-5,9,11H2,1-2H3,(H,18,19)
No information available.
Summary of Clinical Use Click here for help
AQ-13 has completed a Phase 2 proof of concept study for the treatment of uncomplicated P. falciparum malaria in adults (NCT01614964). The per-protocol analysis of results from this clinical trial indicates that AQ-13 is similarly effective when compared to the approved combination therapy of artemether plus lumefantrine (trade name Coartem®)[6].
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT01614964 Studies of a Candidate Aminoquinoline Antimalarial (AQ-13) Phase 2 Interventional Tulane University